SpaceX Rocket and Rate Jitters Collide as iShares MSCI World ETF Faces a Defining Week

The iShares MSCI World ETF enters a week that pits two powerful forces against each other: a potentially historic SpaceX IPO that could force a wave of passive buying, and a stubborn inflation reading that keeps the Federal Reserve on hold. With the fund already nursing a 2.57% weekly loss to close at $200.38, the duelling catalysts promise to test both its structural resilience and its market positioning.

Inflation Data and the Fed’s Grip

Fresh US consumer price figures for May landed on Wednesday, with economists pencilling in a 4.2% annual headline gain — the highest since March 2023. The core rate is expected to hold at 2.9%. A hotter-than-expected print would reinforce the view that inflation is sticky, especially in categories like rents, insurance and services that respond slowly to policy tightening. Goldman Sachs and Bank of America have already scrubbed their rate-cut forecasts for 2026 entirely.

The Federal Reserve meets on 16–17 June — the first gathering under new Chair Kevin Warsh. Markets are pricing a 97% probability that the central bank keeps its benchmark rate unchanged at 3.5%–3.75%. The combination of elevated inflation and a strong labour market — May added 172,000 jobs against a consensus of just 85,000 — leaves little room for a dovish pivot.

SpaceX: A Forced-Buying Event

The real wildcard arrives on Friday. SpaceX is slated to list on the Nasdaq, targeting a valuation of up to $2 trillion and raising $75 billion in the process. MSCI has already activated its fast-track inclusion rule, meaning the space giant could enter the Global Standard Index within ten trading days.

Because only around 7% of SpaceX shares are expected to be freely tradable, the index inclusion will trigger enormous forced buying from passive funds tracking the MSCI World. Analysts anticipate a spike in inflows that could temporarily overwhelm the drag from macro headwinds. The iShares ETF, with its total expense ratio of 0.24%, is one of the primary vehicles for global equity exposure — and a direct beneficiary of that mechanical demand.

Should investors sell immediately? Or is it worth buying MSCI World ETF?

Broadcom’s Slip and the Tech Weighting Hangover

Not all technology names are cooperating. Broadcom delivered a 48% revenue surge to over $22 billion in its latest quarter, but a slight miss on software sales and a lukewarm AI outlook sent the stock crashing more than 12% in a single session to $418.91. Such a move, from a $1 trillion-plus chipmaker, highlights the vulnerability of the ETF’s heavy tech tilt.

The fund allocates 31.43% to technology, with Nvidia at 5.64%, Apple at 5.05% and Microsoft at 3.50%. When rates stay high, the present value of those future earnings shrinks, and the market has proved it will punish even minor disappointments. Annualised volatility for the ETF has climbed to 13.31%.

Pharma Tariffs, Dividends and Competitive Pressure

A less heralded headwind comes from new US tariffs on patented pharmaceuticals. Imports from the EU, Japan, Switzerland and South Korea face a 15% levy; British drugs 10%. Healthcare accounts for 8.39% of the portfolio — not enough to derail the fund, but enough to add a layer of drag for an already stretched index.

In the midst of the turbulence, BlackRock has set the dividend date for 12 June. Shareholders are expected to receive roughly $1.26 per share — up 19% from the June 2025 distribution but below the $1.495 paid out last December. The fund’s price-to-earnings ratio stands at 26.34 and price-to-book at 4.09. Year-to-date, the ETF had gained 10.57% through the end of May, but that cushion is shrinking fast.

With rival asset managers slashing fees on comparable world ETFs, the iShares fund’s 0.24% expense ratio is no longer a clear differentiator. The next fortnight — straddling CPI, a Fed hold, a SpaceX inclusion and a dividend — will reveal whether diversification can still smooth out such concentrated shocks.